Eggemann, Holm <br/><br/>
Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Feb 2018 
 - 337-341 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-017-2539-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Breast Neoplasms, Male--drug therapy<br/>Cohort Studies<br/>Female<br/>Germany--epidemiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Retrospective Studies<br/>Tamoxifen--therapeutic use<br/>Young Adult